Steven Lefkowitz Biography and Net Worth

Director of CorMedix

Mr. Lefkowitz is the Founder of Wade Capital Corporation a financial advisory services company focused on small and middle markets and has been its President since June 1990. Mr. Lefkowitz has also served as a director of both publicly traded and privately held companies. He has been a director of AIS, RE, a privately held reinsurance company since 2001. Mr. Lefkowitz was a director of Franklin Credit Management Corporation, formerly known as Franklin Credit Holding Corporation, a public specialty consumer finance company from 1996 through 2015, and a director and chairman of the board of MedConx, Inc., a privately held medical devices connector company from 2007 through 2015. Mr. Lefkowitz received his A.B. from Dartmouth College in 1977 and his M.B.A. from Columbia University in 1985. Mr. Lefkowitz returns to the board of CorMedix where, as a director from August 2011 to June 2016, he brought his extensive experience in financing micro-cap biotech companies and helped the company successfully complete multiple capital raises. He served as the interim Chief Financial Officer of CorMedix from August 15, 2013 to July 20, 2014.

What is Steven W. Lefkowitz's net worth?: The estimated net worth of Steven W. Lefkowitz is at least $516.80 thousand as of December 9th, 2025. Lefkowitz owns 80,498 shares of CorMedix stock worth more than $516,797 as of March 23rd. This net worth estimate does not reflect any other investments that Lefkowitz may own. Learn More about Steven W. Lefkowitz's net worth.
How do I contact Steven W. Lefkowitz?: The corporate mailing address for Lefkowitz and other CorMedix executives is 300 CONNELL DRIVE SUITE 4200, BERKELEY HEIGHTS NJ, 07922. CorMedix can also be reached via phone at (908) 517-9500 and via email at [email protected]. Learn More on Steven W. Lefkowitz's contact information.
Has Steven W. Lefkowitz been buying or selling shares of CorMedix?: Steven W. Lefkowitz has not been actively trading shares of CorMedix during the past quarter. Most recently, Steven W. Lefkowitz sold 40,000 shares of the business's stock in a transaction on Tuesday, December 9th. The shares were sold at an average price of $11.88, for a transaction totalling $475,200.00. Following the completion of the sale, the director now directly owns 80,498 shares of the company's stock, valued at $956,316.24. Learn More on Steven W. Lefkowitz's trading history.
Who are CorMedix's active insiders?: CorMedix's insider roster includes Alan Dunton (Director), Elizabeth Hurlburt (EVP), Myron Kaplan (Director), Steven Lefkowitz (Director), Erin Mistry (EVP), and Joseph Todisco (CEO). Learn More on CorMedix's active insiders.
Are insiders buying or selling shares of CorMedix?: During the last twelve months, CorMedix insiders bought shares 1 times. They purchased a total of 25,000 shares worth more than $275,500.00. During the last twelve months, insiders at the sold shares 8 times. They sold a total of 253,997 shares worth more than $3,258,817.44. The most recent insider tranaction occured on December, 30th when Director Alan W Dunton sold 20,000 shares worth more than $260,000.00. Insiders at CorMedix own 3.1% of the company. Learn More about insider trades at CorMedix.
Information on this page was last updated on 12/30/2025.

Steven W. Lefkowitz Insider Trading History at CorMedix

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/9/2025	Sell	40,000	$11.88	$475,200.00	80,498
9/4/2020	Buy	5,715	$3.99	$22,802.85	58,283
9/27/2019	Buy	5,000	$6.75	$33,750.00
12/12/2017	Buy	135,416	$0.48	$64,999.68
5/31/2016	Sell	50,000	$2.88	$144,000.00	159,599
5/23/2016	Sell	30,000	$2.93	$87,900.00	132,525
12/13/2013	Buy	18,000	$0.78	$14,040.00

Steven W. Lefkowitz Buying and Selling Activity at CorMedix

CorMedix Company Overview

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Today's Range

Now: $6.42

$6.28

$6.51

50 Day Range

MA: $7.14

$6.25

$8.17

2 Week Range

Now: $6.42

$5.60

$17.43

Volume

1,428,271 shs

Average Volume

2,607,843 shs

Market Capitalization

$507.50 million

P/E Ratio

3.21

Dividend Yield

N/A

Beta

1.31